On September 24, 2020, RAND Corporation released these study results regarding insulin prices in the United States, compared to other countries. The researchers analyzed manufacturer prices from the IQVIA MIDAS data on insulin sales and volume for 2018. They compared the United States insulin prices to prices in 32 nations that belong to the international Organisation for Economic Co-operation and Development (OECD). The report was written by Andrew W. Mulcahy, Daniel Schwam, and Nathaniel Edenfield of RAND Corporation, and sponsored by the Office of the Assistant Secretary for Planning and Evaluation in the U.S. Department of Health and . . .
Industry Resource |